Tribune Therapeutics
PrivateLast Round
Series A
Mar 26, 2025
Total Funding Raised
$57.09M
Momentum Score
25 /100
Company Overview
Tribune Therapeutics is a preclinical biopharmaceutical company developing a pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tribune Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Tribune Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 26, 2025 | ||||
| Seed | Jun 2, 2021 |
Key People
Founding team and executive leadership
Tribune Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inven2 | Seed, Series A |
| Investinor | Series A |
| HealthCap | Series A, Seed |
| Industrifonden | Series A |
| Novo Holdings | Series A, Seed |
| LifeArc Ventures | Series A |
| Innovestor Life Science Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Monthly visitors grew 99% MoM, reaching 1.2K.
- Mar 26, 2025
$40M raised in Seed round.
Tribune Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tribune Therapeutics's valuation, stock price, and market status.
